www.fdanews.com/articles/134561-bayer-starts-phase-iii-nexavar-breast-cancer-trial
Bayer Starts Phase III Nexavar Breast Cancer Trial
February 24, 2011
Bayer and Onyx Pharmaceuticals have started recruiting breast-cancer patients to start the third and last stage of testing their Nexavar pill, a key pipeline drug for both drugmakers.
CNBC
CNBC